Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · IEX Real-Time Price · USD
15.94
-0.02 (-0.13%)
At close: Apr 23, 2024, 4:00 PM
15.57
-0.37 (-2.32%)
After-hours: Apr 23, 2024, 4:38 PM EDT
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $1.36 billion as of April 23, 2024. Its market cap has increased by 17,136.02% in one year.
Market Cap
1.36B
Enterprise Value
1.33B
1-Year Change
17,136.02%
Ranking
Category
Stock Price
$15.94
Market Cap Chart
Since April 12, 2006, Gyre Therapeutics's market cap has increased from $165.40M to $1.36B, an increase of 723.24%. That is a compound annual growth rate of 12.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 1.36B | 2.91% |
Apr 19, 2024 | 1.32B | 0.65% |
Apr 18, 2024 | 1.32B | -2.71% |
Apr 17, 2024 | 1.35B | -1.00% |
Apr 16, 2024 | 1.37B | -2.91% |
Apr 15, 2024 | 1.41B | -1.96% |
Apr 12, 2024 | 1.44B | 2.19% |
Apr 11, 2024 | 1.41B | 18.51% |
Apr 10, 2024 | 1.19B | -18.35% |
Apr 9, 2024 | 1.45B | 0.83% |
Apr 8, 2024 | 1.44B | -0.53% |
Apr 5, 2024 | 1.45B | -0.18% |
Apr 4, 2024 | 1.45B | -1.05% |
Apr 3, 2024 | 1.47B | 1.01% |
Apr 2, 2024 | 1.45B | 7.19% |
Apr 1, 2024 | 1.35B | -9.32% |
Mar 28, 2024 | 1.49B | -0.29% |
Mar 27, 2024 | 1.50B | 3,423.53% |
Mar 26, 2024 | 42.50M | 3.66% |
Mar 25, 2024 | 41.00M | -7.87% |
Mar 22, 2024 | 44.50M | -1.33% |
Mar 21, 2024 | 45.10M | -0.22% |
Mar 20, 2024 | 45.20M | -1.95% |
Mar 19, 2024 | 46.10M | 0.22% |
Mar 18, 2024 | 46.00M | 8.49% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ANI Pharmaceuticals | 1.37B |
Agiliti | 1.37B |
Tilray Brands | 1.34B |
Kura Oncology | 1.33B |
Arcus Biosciences | 1.33B |
Day One Biopharmaceuticals | 1.31B |
NovoCure | 1.29B |
4D Molecular Therapeutics | 1.29B |